methyl 2-[(4-methylphenyl)sulfonylamino]acetate | CAS:2645-02-5

We serve methyl 2-[(4-methylphenyl)sulfonylamino]acetate CAS:2645-02-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
methyl 2-[(4-methylphenyl)sulfonylamino]acetate

Synonyms:
T0514-7020
TsNHCH2COOCH3
 
Molecular Formula:  C10H13NO4S
Molecular Weight: 243.28000
 
Density: 1.261
Boiling point: 372.5ºC at 760 mmHg
Melting point: 89-91ºC

 
Items of Analysis Standard of Analysis Test Results
Appearance White to off-white powder Conform
Assay ≥98.0% 98.46%
Conclusion Conforms to Factory Standard
 

 



Contact us for information like methyl 2-[(4-methylphenyl)sulfonylamino]acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,TsNHCH2COOCH3 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,T0514-7020 Use and application,TsNHCH2COOCH3 technical grade,usp/ep/jp grade.


Related News: In addition, although the API and intermediate industries are capital-intensive and technology-intensive industries, new competitors are still joining.N1-{(1S,2R)-1-(3,5-difluorobenzyl)-3-[(3-furylmethyl)amino]-2-hydroxypropyl}-5-methyl-N3,N3-dipropylisophthalamide manufacturer However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.N-(2-Hydroxy-ethyl)-2-(2-hydroxy-ethylamino)-2-thioxo-acetamide supplier Global Times reported that local officials had been putting up slogans in an effort to get communities to stay at home during the epidemic and to avoid people gathering together to slow and prevent the spread of the coronavirus.dimethyl 2-(1,3-dimethoxy-1,3-dioxopropan-2-yl)cyclohexane-1,1-dicarboxylate vendor He was the partner of a 38-year-old Chinese woman who was travelling with him. She was the first confirmed case reported in the Philippines.International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.